Boehringer Ingelheim taps into Lifebit’s AI for global disease surveillance

That's what drugmaker Boehringer Ingelheim plans to do in an ambitious project with artificial intelligence developer Lifebit, which aims to use natural …

Link to Full Article: Read Here